Testing for Positive Control Activity in a Thorough QTc StudyFootnote∗

∗This paper does not represent the official position of US Food and Drug Administration.

REFERENCES

• Benjamini , Y. , Hochberg , Y. ( 1995 ). Controlling the false discovery rate: A practical and powerful approach to multiple testing . Journal of the Royal Statistical Society 57 : 289 – 300 .
   Google Scholar
• Berger , R. , Hsu , J. ( 1996 ). Bioequivalence trials, intersection–union tests and equivalence confidence sets . Statistical Science 11 : 283 – 319 .
   Web of Science ®Google Scholar
• Boos , D. , Hofffman , D. , Kringe , R. , Zhang , J. ( 2007 ). New confidence bounds for QT studies . Statistics in Medicine 26 : 3801 – 387 .
   PubMed Web of Science ®Google Scholar
• Eaton , M. , Muirhead , R. , Mancuso , J. , Kolluri , S. ( 2006 ). A confidence interval for the maximal mean QT interval change caused by drug effect . Drug Information Journal 40 : 267 – 271 .
   Google Scholar
• Hosmane , B. , Locke , C. ( 2005 ). A simulation study of powering thorough QT/QTc studies and a normal approximation for planning purposes . Drug Information Journal 39 : 447 – 455 .
   Web of Science ®Google Scholar
• ICH . ( 2005 ). ICH E14 Guidance. The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Nonantiarrhythmic Drugs . International Conference on Harmonization , May 2005 , in Geneva, Switzerland .
   Google Scholar
• Julious , S. A. ( 2004 ). Sample sizes for clinical trials with normal data . Statistics in Medicine 23 : 1921 – 1986 .
   PubMed Web of Science ®Google Scholar
• Luo , S. , Michler , K. , Johnston , P. , Macfarlane , P. W. ( 2004 ). A comparison of commonly used QT correction formulae: The effect of heart rate on the QTc of normal ECGs . Journal of Electrocardiology 37 ( Suppl. ): 81 – 90 .
   PubMedGoogle Scholar
• Malik , M. , Färbom , P. , Batchvarov , V. , Hnatkova , K. , Camm , A. J. ( 2002 ). Relation between QT and RR intervals is highly individual among healthy subjects: Implications for heart rate correction of the QT interval . Heart 87 : 220 – 228 .
   PubMed Web of Science ®Google Scholar
• Patterson , S. , Jones , B. ( 2006 ). Bioequivalence and Statistics in Clinical Pharmacology . Chapman & Hall/CRC .
   Google Scholar
• Stass , H. , Dalhoff , A. , Kubitza , D. , Schuhly , U. ( 1998 ). Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects . Antimicrobial Agents in Chemotherapy 42 : 2060 – 2065 .
   PubMed Web of Science ®Google Scholar
• Zhang , J. , Machado , S. ( 2007 ). Current E14-derived approach to design and statistical analysis of TQT studies. Presentation at ACCP Symposium, Baltimore, Maryland, May 2007 .
   Google Scholar
• Zhang , L. , Brian , S. ( 2007 ). Sex differences in QT interval variability and implication on sample size of thorough QT study . Drug Information Journal 41 : 619 – 627 .
   Google Scholar
• ∗This paper does not represent the official position of US Food and Drug Administration.
   Google Scholar